Pear Therapeutics Common Stock

Pear Therapeutics (PEAR) currently reports a common stock of $14K as of December 2022. That compares with $14K in the prior-year period — up 0.0% year over year. Use the charts on this page to explore Pear Therapeutics's common stock history and peer comparisons.

Pear Therapeutics's common stock was unchanged from $14K to $14K — essentially flat versus a year earlier (period ending December 2022). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Pear Therapeutics reported $14K in common stock as of December 2022. That compares with $14K in the prior-year period — up 0.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current common stock of $14K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Pear Therapeutics, and consider following PEAR for alerts when major investors trade the stock.